OpenEvidence unveils new AI model family for clinical decision support

OpenEvidence, a clinical AI startup, has launched a new family of AI models aimed at medical decision support. The move comes amid evolving FDA regulation of AI in healthcare, as signaled by the TEMPO pilot. The competitive impact on the clinical AI market and regulatory implications remain uncertain.